↓ Skip to main content

A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus

Overview of attention for article published in Stem Cell Research & Therapy, April 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

googleplus
1 Google+ user

Citations

dimensions_citation
126 Dimensions

Readers on

mendeley
182 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus
Published in
Stem Cell Research & Therapy, April 2014
DOI 10.1186/scrt446
Pubmed ID
Authors

Xuebin Liu, Pei Zheng, Xiaodong Wang, Guanghui Dai, Hongbin Cheng, Zan Zhang, Rongrong Hua, Xinxin Niu, Jing Shi, Yihua An

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 182 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 <1%
Ireland 1 <1%
Brazil 1 <1%
United Kingdom 1 <1%
Sri Lanka 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 175 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 32 18%
Student > Ph. D. Student 23 13%
Researcher 19 10%
Student > Master 15 8%
Other 10 5%
Other 30 16%
Unknown 53 29%
Readers by discipline Count As %
Medicine and Dentistry 40 22%
Biochemistry, Genetics and Molecular Biology 24 13%
Agricultural and Biological Sciences 23 13%
Nursing and Health Professions 10 5%
Immunology and Microbiology 5 3%
Other 22 12%
Unknown 58 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2014.
All research outputs
#15,528,867
of 23,079,238 outputs
Outputs from Stem Cell Research & Therapy
#1,356
of 2,437 outputs
Outputs of similar age
#134,848
of 227,889 outputs
Outputs of similar age from Stem Cell Research & Therapy
#23
of 30 outputs
Altmetric has tracked 23,079,238 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,437 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,889 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.